Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice

Toxicology and Applied Pharmacology

Volumn 198, Issue 3, 2004, Pages 434-443

  Patterson, Rachel ^a   Vega, Libia ^b   Trouba, Kevin ^a   Bortner, Carl ^a   Germolec, Dori ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Arsenic; Contact hypersensitivity; Flow cytometry; Local lymph node assay

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ARSENIC; FLUORESCEIN ISOTHIOCYANATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL MIGRATION; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; IMMUNE RESPONSE; LANGERHANS CELL; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENICITY; PERITONEUM MACROPHAGE; SKIN SENSITIZATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ARSENITES; CYTOKINES; DERMATITIS, CONTACT; DINITROFLUOROBENZENE; ENZYME INHIBITORS; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; LYMPH NODES; MICE; MICE, INBRED BALB C; SODIUM COMPOUNDS;

ANIMALIA;

EID: 3242781794     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.10.012     Document Type: Article

References (73)

1. Abernathy C., Liu Y., Longfellow D., Aposhian H., Beck B., Fowler B., Goyer R., Menzer R., Rossman T., Thompson C., Waalkes M. Arsenic: health effects, mechanisms of action, and research issues. Environ. Health Perspect. 107:1999;593-597
2. Ariizumi K., Shen G.-L., Shikano S., Xu S., Ritter R.I., Kumamoto T., Edelbaum D., Morita A., Bergstresser P.R., Takashima A. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem. 275:2000;20157-20167
3. Barker J., Mitra R., Griffiths C., Dixit U., Nickoloff B. Keratinocytes as initiators of inflammation. Lancet. 337:1991;211-214
4. Boes M., Cerny J., Massol R., Op den Brouw M., Kirchhausen T., Chen J., Ploegh H.L. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature. 418:2002;983-988
5. Burns L., McCay J., Brown R., Munson A. Arsenic in the sera of gallium arsenide-exposed mice inhibits bacterial growth and increases host resistance. J. Pharmacol. Exp. Ther. 265:1993;795-800
6. Caffrey-Nolan R.E., McCoy K.L. Direct exposure to gallium arsenide upregulates costimulatory activity of murine macrophages. Toxicol. Appl. Pharmacol. 151:1998;330-339
7. Christensen J., Poulsen O. A 1982-1992 Surveillance Programmme on Danish pottery painters. Biological levels and health effects following exposure to soluble or insoluble cobalt compounds in cobalt blue dyes. Sci. Total Environ. 150:1994;95-104
8. Cline M.J. The White Cell. 1975;Harvard Univ. Press, Cambridge, MA
9. Corsini E., Galli C. Epidermal cytokines in experimental contact dermatitis. Toxicology. 142:2000;203-211
10. Corsini E., Asti L., Viviani B., Marinovich M., Galli C. Sodium arsenate induces overproduction of interleukin-1α in murine keratinocytes: role of mitochondria. J. Invest. Dermatol. 113:1999;760-765
11. Cumberbatch M., Gould S., Peters S., Basketter D., Dearman R.J., Kimber I. Langerhans cells, antigen presentation, and the diversity of responses to chemical allergens. J. Invest. Dermatol. 99:1992;107S-108S
12. Cumberbatch M., Dearman R.J., Kimber I. Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1β Immunology. 105:2002;466-477
13. Cuzick J., Sasieni P., Evans S. Ingested arsenic, keratoses, and bladder cancer. Am. J. Epidemiol. 136:1992;417-421
14. 3) on myeloma cells. Leuk. Res. 25:2001;227-235
15. Dean J.H., Twerdok L.E., Tice R.R., Sailstad D., Hattan D., Stokes W. ICCVAM evaluation of the murine local lymph node assay II. Conclusions and recommendations of an independent scientific peer review panel. Regul. Toxicol. Pharmacol. 34:2001;258-273
16. Dearstyne E., Kerkvliet N. Mechanism of 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD)-induced decrease in anti-CD3-activated CD4+ T cells: the roles of apoptosis, Fas and TNF. Toxicology. 170:2002;139-151
17. Ernst E. Adverse effects of herbal drugs in dermatology. Br. J. Dermatol. 143:2000;923-929
18. Fetterhoff T., Holland S., Wile K. Fluorescent detection of non-viable cells fixed in cell preparations. Cytometry. 14:1993;27
19. Flora S.J., Kumar P., Kannan G.M., Rai G.P. Acute oral gallium arsenide exposure and changes in certain hematological, hepatic, renal and immunological indices at different time intervals in male Wistar rats. Toxicol. Lett. 94:1998;103-113
20. Gad S.C. The mouse ear swelling test (MEST) in the 1990s. Toxicology. 93:1994;33-46
21. Germolec D.R., Yoshida T., Gaido K., Wilmer J.L., Simeonova P.P., Kayama F., Burleson F., Dong W., Lange R.W., Luster M.I. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol. 141:1996;308-318
22. Germolec D.R., Spalding J., Yu H.-S., Chen G.S., Simeonova P.P., Humble M., Bruccoleri A., Boorman G., Foley J.F., Yoshida T., Luster M.I. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol. 153:1998;1775-1785
23. Gomez-Caminero A., Howe P., Hughes M., Kenyon E., Lewis D., Moore M., Ng J., Aitio A., Becking G. Arsenic and arsenic compounds. Environ. Health Criteria. vol. 224:2001;20-23 The International Programme on Chemical Safety World Health Organization, Geneva, Switzerland
24. Gottlieb A., Chang C., Posnett D., Fanelli B., Tam J. Detection of transforming growth factor alpha in normal malignant and hyperproliferative human keratinocytes. J. Exp. Med. 167:1988;670-675
25. Greene E.C. Anatomy of the Rat. 1935;Hafner Press, New York
26. Hall A.H. Chronic arsenic poisoning. Toxicol. Lett. 128:2002;69-72
27. Haneke K.E., Tice R.R., Carson B.L., Margolin B.H., Stokes W. ICCVAM evaluation of the murine local lymph node assay III. Data analyses completed by the national toxicology program interagency center for the evaluation of alternative toxicological methods. Regul. Toxicol. Pharmacol. 34:2001;274-286
28. Harrison M.T., Hartmann C.B., McCoy K.L. Impact of in vitro gallium arsenide exposure on macrophages. Toxicol. Appl. Pharmacol. 186:2003;18-27
29. Hartmann C.B., McCoy K.L. Gallium arsenide augments antigen processing by peritoneal macrophages for CD4+ helper T cell stimulation. Toxicol. Appl. Pharmacol. 141:1996;365-372
30. Hayes B.B., Meade B.J. Contact sensitivity to selected acrylate compounds in B6C3F1 mice: relative potency, cross reactivity, and comparison of test methods. Drug Chem. Toxicol. 22:1999;491-506
31. Hayes B.B., Gerber P.C., Griffey S.S., Meade B.J. Contact hypersensitivity to dicyclohexylcarbodiimide and diisopropylcarbodiimide in female B6C3F1 mice. Drug Chem. Toxicol. 21:1998;195-206
32. Huaux F., Lasfargues G., Lauwerys R., Lison D. Lung toxicity of hard metal particles and production of interleukin-1, tumor necrosis factor-a, fibronectin, and cystatin-c by lung phagocytes. Toxicol. Appl. Pharmacol. 132:1995;53-62
33. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133:2002;1-16
34. Inaba K., Schuler G., Witmer M., Valinsky J., Atassi B., Steinman R. Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J. Exp. Med. 164:1986;605-613
35. 2+ in combination. Hum. Exp. Toxicol. 20:2001;329-336
36. Kimber I. Chemical-induced hypersensitivity. Holsapple M.P. Experimental Immunotoxicolgy. 1996;391-417 CRC Press, New York
37. Kimber I., Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J. Invest. Dermatol. 55:1992;48S-50S
38. Kitchin K. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172:2001;249-261
39. Lansdown A.B. Physiological and toxicological changes in the skin resulting from the action and interaction of metal ions. Crit. Rev. Toxicol. 25:1995;397-462
40. Lantz R.C., Parliman G., Chen G.J., Carter D.E. Effect of arsenic exposure on alveolar macrophage function I. Effect of soluble as (III) and as(IV). Environ. Res. 67:1994;183-195
41. Lantz R., Parliman G., Chen G., Barber D., Winski S., Carter D. Effect of arsenic exposure on alveolar macrophage function II. Effect of slightly soluble forms of as (III) and as (V). Environ. Res. 68:1995;59-67
42. Lecoeur H., de Oliveira-Pinto L.M., Gougeon M.-L. Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay. J. Immunol. Methods. 265:2002;81-96
43. Lewis T., Munson A., McCoy K.L. Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation. J. Pharmacol. Exp. Ther. 278:1996;1244-1251
44. Lewis T., Hartmann C.B., McCoy K.L. Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages. J. Immunol. 161:1998;2151-2157
45. Luger T., Schwartz T. Epidermal cell-derived cytokines. Bos J. Skin Immune System. 1990;257-291 CRC Press, Boca Raton, FL
46. McCabe M., Maguire D., Nowak M. The effects of arsenic compounds on human and bovine lymphocyte mitogenesis in vitro. Environ. Res. 31:1983;323-331
47. Meng Z. Effects of arsenite on DNA synthesis in human lymphocytes stimulated by phytohemagglutin. Biol. Trace Elem. Res. 39:1993;73-80
48. Montgomery C. Oncologic and toxicologic research: alleviation and control of pain and distress in laboratory animals. Cancer Bull. 42:1990;230-237
49. Morton D., Griffiths P. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet. Rec. 116:1985;431-436
50. Paine R.I., Morris S.B., Jin H., Wilcoxen S.E., Phare S.M., Moore B.B., Coffey M.J., Toews G.B. Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:2001;L1210-L1218
51. Rahman M., Wingren G., Axelson O. Diabetes mellitus among Swedish art glass workers - An effect of arsenic exposure? Scand. J. Work, Environ. Health. 22:1996;146-149
52. Rodgers K., Xiong S. Effect of Administration of Malathion for 90 days on macrophage function and mast cell degranulation. Toxicol. Lett. 93:1997;73-82
53. Ryan P., Huet N., MacIntosh D. Longitudinal investigation of exposure to arsenic, cadmium, and lead in drinking water. Environ. Health Perspect. 108:2000;731-735
54. Sailstad D., Hattan D., Hill R., Stokes W. ICCVAM evaluation of the murine local lymph node assay I. The ICCVAM review process. Regul. Toxicol. Pharmacol. 34:2001;249-257
55. Sakurai T., Kaise T., Matsuara C. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Chem. Res. Toxicol. 11:1998;273-283
56. Savabieasfahani R., Lochmiller R., Rafferty D., Sinclair J. Sensitivity of wild cotton rats (Sigmodon hispidus) to the immunotoxic effects of low-level arsenic exposure. Arch. Environ. Contam. Toxicol. 34:1998;289-296
57. Schultz H., Nagymajenyi L., Institoris L., Papp A., Siroki O. A study on behavioral, neurotoxicological, and immunotoxicological effects of subchronic arsenic treatment in rats. J. Toxicol. Environ. Health, Part A. 65:2002;1181-1193
58. Scott A.E., Kashon M.L., Yucesoy B., Luster M.I., Tinkle S. Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactions. Toxicol. Appl. Pharmacol. 183:2002;66-70
59. Sikorski E., McCay J., White K., Bradley S., Munson A. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam. Appl. Toxicol. 13:1989;843-858
60. Sikorski E., Burns L., Stern M., Luster M.I., Munson A. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response. Toxicol. Appl. Pharmacol. 110:1991;129-142
61. Su S.-H., Chen H.-I., Jen C.J. C57BL/6 and BALB/c bronchoalveolar macrophages respond differently to exercise. J. Immunol. 167:2001;5084-5091
62. USEPA. 1987. US Environmental Protection Agency: Special Report on Ingested Inorganic Arsenic: Skin Cancer and Nutritional Essentiality. Risk Assessment Forum. US Environmental Protection Agency, Washington, DC.
63. USEPA National Primary Drinking Water Regulations; Arsenic and Clarifications to Compliance and New Source Contaminants Monitoring; Final Rule. 2001;6976 US Environmental Protection Agency, Washington, DC
64. Vasunia K., Miller M., Puga A., Baxter C. Granulocyte-macrophage colony stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers. Carcinogenesis. 15:1994;653-660
65. Vega L., Ostrosky-Wegman P., Fortoul T., Diaz C., Madrid V., Saavedra R. Sodium arsenite reduces proliferation of human activated T-cells by inhibition of the secretion of inerleukin-2. Immunopharmacol. Immunotoxicol. 21:1999;203-220
66. Vega L., Styblo M., Patterson R., Cullen W., Wang C., Germolec D.R. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 172:2001;225-232
67. Wang B., Lee Y., Mak C., Kao H., Hsu M., Hsien J. Quantitative and morphological changes of Langerhans cells in Bowen's disease from patients with chronic arsenicism. J. Formosan Med. Assoc. 90:1991;1093-1098
68. Wang L., Brown J.R., Varki A., Esko J. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J. Clin. Invest. 110:2002;127-136
69. WHO Guidelines for Drinking-Water Quality. 1993;World Health Organization, Geneva
70. Wingren G., Axleson O. Epidemiologic studies of occupational cancer as related to complex mixtures of trace elements in the art glass industry. Scand. J. Work, Environ. Health. 19:1993;95-100
71. Wong S., Chan H., Teo S. The spectrum of cutaneous and internal malignancies in chronic arsenic toxicity. Singapore Med. J. 39:1998;171-173
72. Yoshida T., Shimamura T., Shigeta S. Immunological effects of arsenic compounds on mouse spleen cells in vitro. Tokai J. Exp. Clin. Med. 11:1986;353-359
73. Yu H.-S., Liao W.-T., Chang K.-L., Yu C.-L., Chen G.-S. Arsenic induces tumor necrosis factor a release and tumor necrosis factor receptor 1 signaling in T helper cell apoptosis. J. Invest. Dermatol. 119:2002;812-819